Study: CBDa and CBGa prevent Covid infection
A new study adds further confirmation to the effect of cannabis on the Covid. In a laboratory study published in the Journal of Nature Products, researchers from’Oregon State University have tested the potential of CBDa and CBGa, the acidic versions of CBD and CBG, to combat coronavirus.
These two active ingredients found in hemp and cannabis prevented the virus that causes Covid-19 from entering healthy human cells, according to the study, by binding to spike proteins (proteins spike) present on the virus and blocking a step the pathogen uses to infect people.
The researchers tested the effect of the compounds against alpha and beta variants of the virus in the laboratory. The study did not involve administering the supplements to individuals or comparing infection rates in those using the compounds and those not.
«These compounds can be taken orally and have a long history of safe use in humans,» said Richard van Breemen, researcher at the Global Hemp Innovation Center from Oregon. «They have the potential to prevent as well as treat SARS-CoV-2 infection,» he added. in a press release.
Previous studies have also highlighted the contribution of THC to treat fatal complications of COVID-19 or the CBD on Covid-generated inflammation.
Democratic senators are reviving a bill to legalize cannabis at the federal level in the United States
A THC:CBD oil shows promising results in reducing agitation in people with dementia
San Francisco Allows «Cannabis Cafés»
Kenya Denies Rastafarians the Right to Use Cannabis
German patients prefer medical cannabis with a high THC content
Curaleaf Is the First to Register Medical Cannabis Products in Spain
South Australia is working to identify more water-efficient hemp varieties
Massachusetts voters will vote in November on whether to repeal the legalization of cannabis
[Le trois-feuilles] The 2026 World Cup Provides a Global Showcase for Legal Cannabis
Wyoming Rejects the Reclassification of Cannabis
-
Cannabis in France4 weeks agoFrance Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France4 weeks ago
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact
-
Cannabis in Switzerland3 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project
You must be logged in to post a comment Login